These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12928586)

  • 1. Ribozymes: a modern tool in medicine.
    Khan AU; Lal SK
    J Biomed Sci; 2003; 10(5):457-67. PubMed ID: 12928586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribozymes in the age of molecular therapeutics.
    Bagheri S; Kashani-Sabet M
    Curr Mol Med; 2004 Aug; 4(5):489-506. PubMed ID: 15267221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribozymes as therapeutic tools for genetic disease.
    Phylactou LA; Kilpatrick MW; Wood MJ
    Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic applications of catalytic antisense RNAs (ribozymes).
    Rossi JJ
    Ciba Found Symp; 1997; 209():195-204; discussion 204-6. PubMed ID: 9383577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribozyme gene therapy: applications for molecular medicine.
    Lewin AS; Hauswirth WW
    Trends Mol Med; 2001 May; 7(5):221-8. PubMed ID: 11325634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribozymes: recent advances in the development of RNA tools.
    Puerta-Fernández E; Romero-López C; Barroso-delJesus A; Berzal-Herranz A
    FEMS Microbiol Rev; 2003 Apr; 27(1):75-97. PubMed ID: 12697343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic acid enzymes as a novel generation of anti-gene agents.
    Sioud M
    Curr Mol Med; 2001 Nov; 1(5):575-88. PubMed ID: 11899232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic applications of ribozymes.
    Kijima H; Ishida H; Ohkawa T; Kashani-Sabet M; Scanlon KJ
    Pharmacol Ther; 1995; 68(2):247-67. PubMed ID: 8719970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the substrate specificity of a group I intron ribozyme.
    Zarrinkar PP; Sullenger BA
    Biochemistry; 1999 Mar; 38(11):3426-32. PubMed ID: 10079089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribozymes of the hepatitis delta virus: recent findings on their structure, mechanism of catalysis and possible applications.
    Ciesiolka J; Wrzesinski J; Legiewicz M; Smólska B; Dutkiewicz M
    Acta Biochim Pol; 2001; 48(2):409-18. PubMed ID: 11732611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group I intron ribozymes.
    Nielsen H
    Methods Mol Biol; 2012; 848():73-89. PubMed ID: 22315064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure and function of catalytic RNAs.
    Wu Q; Huang L; Zhang Y
    Sci China C Life Sci; 2009 Mar; 52(3):232-44. PubMed ID: 19294348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes.
    Byun J; Lan N; Long M; Sullenger BA
    RNA; 2003 Oct; 9(10):1254-63. PubMed ID: 13130139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribozyme: a clinical tool.
    Khan AU
    Clin Chim Acta; 2006 May; 367(1-2):20-7. PubMed ID: 16426595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic RNA, ribozyme, and its applications in synthetic biology.
    Park SV; Yang JS; Jo H; Kang B; Oh SS; Jung GY
    Biotechnol Adv; 2019 Dec; 37(8):107452. PubMed ID: 31669138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.
    Rossi JJ; Elkins D; Taylor N; Zaia J; Sullivan S; Deshler JO
    Antisense Res Dev; 1991; 1(3):285-8. PubMed ID: 1821650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Productive folding to the native state by a group II intron ribozyme.
    Swisher JF; Su LJ; Brenowitz M; Anderson VE; Pyle AM
    J Mol Biol; 2002 Jan; 315(3):297-310. PubMed ID: 11786013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group II Intron Self-Splicing.
    Pyle AM
    Annu Rev Biophys; 2016 Jul; 45():183-205. PubMed ID: 27391926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function relationships of hammerhead ribozymes: from understanding to applications.
    Sigurdsson ST; Eckstein F
    Trends Biotechnol; 1995 Aug; 13(8):286-9. PubMed ID: 7662303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.